AKAP4 and non-small cell lung carcinoma: Gumireddy et al. identified AKAP4 as a potential biomarker for NSCLC by analyzing CTA messenger ribonucleic acids (mRNAs) in peripheral blood monocytes isolated from 116 patients with NSCLC, which was further verified in 264 patients and 135 healthy volunteers.